Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-06-17 4:07 pm Sale | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,807 15.3% | -1 (-0.00%) | View |
2020-06-11 11:43 am Unchanged | 13G | THERAVANCE BIOPHARMA INC TBPH | ACACIA RESEARCH CORP ACTG | 0 0% | 0 (Unchanged) | View |
2020-03-09 4:31 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 8,682,679 13.9% | 4,853,600 (+126.76%) | View |
2020-02-27 4:48 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,808 15.5% | 0 (Unchanged) | View |
2020-02-18 4:37 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK plc GSK | 9,644,808 15.5% | 0 (Unchanged) | View |
2020-02-12 11:08 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 4,003,602 7.05% | 23,542 (+0.59%) | View |
2020-02-07 11:32 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | FMR LLC | 8,524,173 14.999% | 187,447 (+2.25%) | View |
2020-02-06 09:23 am Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 3,829,079 6.7% | -33,997 (-0.88%) | View |
2020-01-28 09:49 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | WELLINGTON MANAGEMENT GROUP LLP | 3,177,537 5.6% | 3,177,537 (New Position) | View |
2019-11-08 3:01 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | Woodford Investment Management Ltd | 429,770 0.76% | -11,886,759 (-96.51%) | View |
2019-10-30 08:09 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Link Fund Solutions Ltd | 5,251,349 9.27% | 5,251,349 (New Position) | View |